Trial
NCT03962725
Avoiding Neuromuscular Blockers to Reduce Complications
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
—
Condition
Respiratory Failure
Intervention
Neuromuscular Blocking Agents
Why stopped
Study terminated due to lack of enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04